Skip to main content
PSNL
NASDAQ Industrial Applications And Services

Personalis Files Schedule 13E-3: Tempus Merger Terms Finalized with $16.25 Floor Price and Cash Election Option

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$16.7
Mkt Cap
$1.792B
52W Low
$4.652
52W High
$18.89
52W Position info
259% above low
Off High info
12% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

PSNL has more than doubled off its 52-week low of $4.652.

Summary

Personalis filed its Schedule 13E-3 detailing the merger terms with Tempus AI: a $1.85 billion transaction with a $16.25 per share floor price, exchange ratio mechanics, and a cash election option for up to 50% of consideration.


Key Events · M&A and Partnerships · PSNL

  • Merger Terms Finalized

    Exchange ratio set at 0.3356 Tempus shares per Personalis share if Tempus stock price is ≤ $48.42, or $16.25 divided by Tempus stock price if above. Tempus may elect to pay cash for up to 50% of consideration.

  • Transaction Valuation

    Filing fee table values the transaction at $1,849,298,539.70 based on 109,296,604 shares at $16.92 per share (average of high and low on August 28, 2026).

  • Merck Voting Agreement

    Merck, holding approximately 13% voting power, agreed to vote all its Personalis shares in favor of the merger and against competing proposals.

  • S-4 Registration Filed

    Tempus concurrently filed a Form S-4 registration statement containing the preliminary proxy statement/prospectus for the Personalis special meeting.


Analysis · PSNL · Industrial Applications And Services

This Schedule 13E-3 formalizes the going-private transaction mechanics for the Tempus AI acquisition of Personalis. The filing quantifies the deal at $1.85 billion and reveals the exchange ratio structure: Personalis shareholders receive 0.3356 Tempus shares if Tempus trades at or below $48.42, or $16.25 worth of Tempus stock if above. Tempus can elect to pay cash for up to 50% of the consideration. Merck, holding 13% voting power, has agreed to vote in favor. The deal remains subject to shareholder approval and closing conditions.

How filings like this one have moved

In the 30 days to Sep 13, 2026, 35.6% of the 1268 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PSNL was trading at $16.70 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $4.65 to $18.89. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PSNL - Latest Insights

PSNL
Aug 04, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $13.29
Real-time Price: $16.21 info
Change: +$2.92 (+22%) info
Market Cap: $1.731B info
PSNL
Jul 20, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $13.30
Real-time Price: $16.21 info
Change: +$2.91 (+22%) info
Market Cap: $1.731B info
PSNL
Jul 20, 2026, 9:19 AM EDT
Filing Type: 425
Importance Score:
10
Price at Filing: $14.43
Real-time Price: $16.21 info
Change: +$1.78 (+12%) info
Market Cap: $1.731B info
PSNL
Jul 20, 2026, 9:18 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $14.43
Real-time Price: $16.21 info
Change: +$1.78 (+12%) info
Market Cap: $1.731B info
PSNL
Jul 20, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $15.49
Real-time Price: $16.21 info
Change: +$0.720 (+5%) info
Market Cap: $1.731B info